+
データを開く
-
基本情報
登録情報 | データベース: PDB / ID: 1qql | ||||||
---|---|---|---|---|---|---|---|
タイトル | THE CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR 7/1 CHIMERA | ||||||
![]() | Fibroblast growth factor 7, Fibroblast growth factor 1 chimera | ||||||
![]() | HORMONE/GROWTH FACTOR / BETA-TREFOIL / HORMONE-GROWTH FACTOR COMPLEX | ||||||
機能・相同性 | ![]() secretion by lung epithelial cell involved in lung growth / FGFR2b ligand binding and activation / SHC-mediated cascade:FGFR2 / FRS-mediated FGFR2 signaling / type 2 fibroblast growth factor receptor binding / PI-3K cascade:FGFR2 / PI3K Cascade / Phospholipase C-mediated cascade; FGFR2 / PIP3 activates AKT signaling / positive regulation of keratinocyte proliferation ...secretion by lung epithelial cell involved in lung growth / FGFR2b ligand binding and activation / SHC-mediated cascade:FGFR2 / FRS-mediated FGFR2 signaling / type 2 fibroblast growth factor receptor binding / PI-3K cascade:FGFR2 / PI3K Cascade / Phospholipase C-mediated cascade; FGFR2 / PIP3 activates AKT signaling / positive regulation of keratinocyte proliferation / Negative regulation of FGFR2 signaling / PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling / mesonephric epithelium development / branch elongation involved in ureteric bud branching / regulation of endothelial tube morphogenesis / positive regulation of epithelial cell proliferation involved in lung morphogenesis / FGFR3b ligand binding and activation / regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling / regulation of endothelial cell chemotaxis to fibroblast growth factor / phosphatidylcholine biosynthetic process / Signaling by activated point mutants of FGFR3 / FGFR3c ligand binding and activation / Phospholipase C-mediated cascade; FGFR3 / positive regulation of myoblast proliferation / positive regulation of keratinocyte migration / mesenchymal cell proliferation / FGFR2b ligand binding and activation / fibroblast growth factor receptor binding / FGFR2c ligand binding and activation / Activated point mutants of FGFR2 / FGFR4 ligand binding and activation / Phospholipase C-mediated cascade; FGFR2 / FGFR1b ligand binding and activation / phospholipid biosynthetic process / Phospholipase C-mediated cascade; FGFR4 / Signaling by activated point mutants of FGFR1 / FGFR1c ligand binding and activation / organ induction / Downstream signaling of activated FGFR1 / branching involved in salivary gland morphogenesis / Phospholipase C-mediated cascade: FGFR1 / regulation of synapse maturation / surfactant homeostasis / S100 protein binding / endothelial cell proliferation / RAF/MAP kinase cascade / protein localization to cell surface / hair follicle morphogenesis / Signaling by FGFR2 IIIa TM / PI-3K cascade:FGFR3 / PI-3K cascade:FGFR2 / PI-3K cascade:FGFR4 / positive chemotaxis / PI-3K cascade:FGFR1 / positive regulation of sprouting angiogenesis / chemoattractant activity / positive regulation of MAP kinase activity / positive regulation of intracellular signal transduction / myoblast proliferation / positive regulation of cell division / PI3K Cascade / anatomical structure morphogenesis / fibroblast growth factor receptor signaling pathway / activation of protein kinase B activity / SHC-mediated cascade:FGFR3 / SHC-mediated cascade:FGFR2 / SHC-mediated cascade:FGFR4 / SHC-mediated cascade:FGFR1 / ovarian follicle development / FRS-mediated FGFR3 signaling / FRS-mediated FGFR2 signaling / FRS-mediated FGFR4 signaling / Signaling by FGFR3 in disease / FRS-mediated FGFR1 signaling / neurogenesis / Signaling by FGFR2 in disease / positive regulation of endothelial cell proliferation / Signaling by FGFR1 in disease / extracellular matrix / positive regulation of endothelial cell migration / lung development / Negative regulation of FGFR3 signaling / regulation of cell migration / Negative regulation of FGFR2 signaling / Negative regulation of FGFR4 signaling / Negative regulation of FGFR1 signaling / epithelial cell proliferation / positive regulation of epithelial cell proliferation / growth factor activity / wound healing / positive regulation of cholesterol biosynthetic process / GABA-ergic synapse / integrin binding / positive regulation of angiogenesis / Constitutive Signaling by Aberrant PI3K in Cancer / PIP3 activates AKT signaling / heparin binding / cellular response to heat / RAF/MAP kinase cascade / PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling 類似検索 - 分子機能 | ||||||
生物種 | ![]() ![]() ![]() | ||||||
手法 | ![]() ![]() | ||||||
![]() | Ye, S. / Luo, Y. / Pelletier, H. / McKeehan, W.L. | ||||||
![]() | ![]() タイトル: Structural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifs. 著者: Ye, S. / Luo, Y. / Lu, W. / Jones, R.B. / Linhardt, R.J. / Capila, I. / Toida, T. / Kan, M. / Pelletier, H. / McKeehan, W.L. #1: ![]() タイトル: The glycine box: a determinant of specificity for fibroblast growth factor. 著者: Luo, Y. / Lu, W. / Mohamedali, K.A. / Jang, J.H. / Jones, R.B. / Gabriel, J.L. / Kan, M. / McKeehan, W.L. #2: ![]() タイトル: Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. 著者: Finch, P.W. / Rubin, J.S. / Miki, T. / Ron, D. / Aaronson, S.A. #3: ![]() タイトル: Structure of a heparin-linked biologically active dimer of fibroblast growth factor. 著者: DiGabriele, A.D. / Lax, I. / Chen, D.I. / Svahn, C.M. / Jaye, M. / Schlessinger, J. / Hendrickson, W.A. #4: ![]() タイトル: Heparin structure and interactions with basic fibroblast growth factor. 著者: Faham, S. / Hileman, R.E. / Fromm, J.R. / Linhardt, R.J. / Rees, D.C. | ||||||
履歴 |
|
-
構造の表示
構造ビューア | 分子: ![]() ![]() |
---|
-
ダウンロードとリンク
-
ダウンロード
PDBx/mmCIF形式 | ![]() | 42.8 KB | 表示 | ![]() |
---|---|---|---|---|
PDB形式 | ![]() | 30.3 KB | 表示 | ![]() |
PDBx/mmJSON形式 | ![]() | ツリー表示 | ![]() | |
その他 | ![]() |
-検証レポート
文書・要旨 | ![]() | 416 KB | 表示 | ![]() |
---|---|---|---|---|
文書・詳細版 | ![]() | 420.9 KB | 表示 | |
XML形式データ | ![]() | 11 KB | 表示 | |
CIF形式データ | ![]() | 14.7 KB | 表示 | |
アーカイブディレクトリ | ![]() ![]() | HTTPS FTP |
-関連構造データ
-
リンク
-
集合体
登録構造単位 | ![]()
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||
単位格子 |
|
-
要素
#1: タンパク質 | 分子量: 16433.945 Da / 分子数: 1 断片: DUAL-FUNCTION CHIMERA BETWEEN RAT FGF-7 ENCODED BY EXON 1 AND 2 AND HUMAN FGF-1 ENCODED BY EXON 3,DUAL-FUNCTION CHIMERA BETWEEN RAT FGF-7 ENCODED BY EXON 1 AND 2 AND HUMAN FGF-1 ENCODED BY EXON 3 由来タイプ: 組換発現 由来: (組換発現) ![]() ![]() ![]() 属: Rattus, Homo / 生物種: , / 株: , / 解説: NONE / 遺伝子: Fgf7, FGF1, FGFA / プラスミド: PGEX-2T / 生物種 (発現宿主): Escherichia coli / 発現宿主: ![]() ![]() 参照: UniProt: Q9ERN5, UniProt: P05230, UniProt: Q02195*PLUS |
---|---|
#2: 水 | ChemComp-HOH / |
-実験情報
-実験
実験 | 手法: ![]() |
---|
-
試料調製
結晶 | マシュー密度: 2.32 Å3/Da / 溶媒含有率: 46.96 % | ||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
結晶化 | 温度: 298 K / 手法: 蒸気拡散法, シッティングドロップ法 / pH: 7 詳細: SODIUM PHOSPHATE, POTASSIUM PHOSPHATE, SODIUM SULPHATE, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K | ||||||||||||||||||||||||||||||||||||||||||||||||
結晶化 | *PLUS 温度: 20 ℃ | ||||||||||||||||||||||||||||||||||||||||||||||||
溶液の組成 | *PLUS
|
-データ収集
回折 |
| ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
放射光源 |
| ||||||||||||||||||||
検出器 |
| ||||||||||||||||||||
放射 |
| ||||||||||||||||||||
放射波長 |
| ||||||||||||||||||||
反射 | 解像度: 2.3→30 Å / Num. all: 7140 / Num. obs: 7140 / % possible obs: 96.8 % / Observed criterion σ(F): 0 / Observed criterion σ(I): 0 / 冗長度: 9 % / Rmerge(I) obs: 0.065 / Net I/σ(I): 28.1 | ||||||||||||||||||||
反射 シェル | 解像度: 2.3→2.38 Å / 冗長度: 7.8 % / Rmerge(I) obs: 0.299 / % possible all: 95 | ||||||||||||||||||||
反射 | *PLUS 最低解像度: 30 Å / Num. measured all: 64157 | ||||||||||||||||||||
反射 シェル | *PLUS % possible obs: 95 % |
-
解析
ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 解像度: 2.3→6 Å / σ(F): 2 / σ(I): 2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 2.3→6 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ソフトウェア | *PLUS 名称: ![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化 | *PLUS 最高解像度: 2.3 Å / 最低解像度: 6 Å / σ(F): 2 / Rfactor obs: 0.237 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶媒の処理 | *PLUS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ | *PLUS |